Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib plus Cetuximab in refractory wtKRAS metastatic colorectal cancer
NCT01919879Phase 2Completed
- Sponsor
- Unicancer
- Start
- Oct 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in metastatic colorectal cancer (mCRC), sponsored by Unicancer. Started Oct 2012; status: completed.
02
Drugs
afatinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01919879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919879.